Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $51.30 USD
Change Today +0.49 / 0.96%
Volume 488.9K
ALR On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 8:04 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

alere inc (ALR) Snapshot

Open
$50.88
Previous Close
$50.81
Day High
$51.53
Day Low
$50.82
52 Week High
05/22/15 - $51.53
52 Week Low
08/4/14 - $33.76
Market Cap
4.3B
Average Volume 10 Days
377.7K
EPS TTM
$-1.22
Shares Outstanding
84.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ALERE INC (ALR)

alere inc (ALR) Related Businessweek News

View More BusinessWeek News

alere inc (ALR) Details

Alere Inc. provides point-of-care diagnostics and services for infectious and cardiometabolic diseases, and toxicology and in the United States and internationally. It operates in three segments: Professional Diagnostics, Patient Self-Testing, and Consumer Diagnostics. The Professional Diagnostics segment provides diagnostic test products and other in vitro diagnostic tests to medical professionals and laboratories for detection of diseases and conditions in the areas of viral hepatitis; respiratory syncytial virus; influenza; pneumonia; tuberculosis; human immunodeficiency virus/acquired immunodeficiency syndrome; gastrointestinal disease; vector-borne diseases, such as malaria and dengue; and herpes and other sexually-transmitted diseases, as well as diabetes, high blood pressure, high cholesterol, metabolic syndrome, coronary artery disease, heart attack, and heart failure and stroke. The Patient-Self Testing segment provides home monitoring patient self-testing services that support anticoagulation management through frequent self-testing by patients who take warfarin to control their risk for stroke and clotting disorders. The Consumer Diagnostics segment provides products for over-the-counter pregnancy and fertility/ovulation test markets; and over-the-counter drug tests for at-home testing and cholesterol monitoring under the First Check brand name, as well as vaginal gel for the treatment of bacterial vaginosis without antibiotics. Alere Inc. markets its professional diagnostic products to hospitals, reference laboratories, physician offices, and other point-of-care settings through its sales force and distribution networks; and First Check consumer drug testing products through retail drug stores, drug wholesalers, groceries, and mass merchandisers. The company was formerly known as Inverness Medical Innovations, Inc. and changed its name to Alere Inc. in July 2010. Alere Inc. was founded in 1981 and is headquartered in Waltham, Massachusetts.

9,800 Employees
Last Reported Date: 03/5/15
Founded in 1981

alere inc (ALR) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $882.1K
Global President of Toxicology
Total Annual Compensation: $650.0K
Global President of Cardiometabolic Business ...
Total Annual Compensation: $548.1K
Global President of Infectious Disease Busine...
Total Annual Compensation: $486.3K
Executive officer
Total Annual Compensation: $425.1K
Compensation as of Fiscal Year 2014.

alere inc (ALR) Key Developments

Alere Inc. announced delayed 10-Q filing

On 05/12/2015, Alere Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

Alere Inc. Reports Preliminary Consolidated Earnings Results for the First Quarter Ended March 31, 2015; Provides Earnings Guidance for the Year Ending December 31, 2015

Alere Inc. reported preliminary consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company's net revenue was $610.4 million, a decrease of 2.4%, compared to $625.2 million in the first quarter of 2014. Non-GAAP adjusted net revenue was $610.7 million, a decrease of 2.4%, compared to $625.7 million in the first quarter of 2014. Net revenue in the first quarter of 2015 included negative foreign currency impact of $28.7 million. Operating income was $29.7 million in the first quarter of 2015. On a non-GAAP basis, adjusted operating income was $117.4 million in the first quarter of 2015. Loss from continuing operations available to common stockholders was $9.2 million or $0.11 per diluted share in the first quarter of 2015. On a non-GAAP basis, the company reported adjusted income from continuing operations available to common stockholders of $50.4 million, or $0.57 per diluted share in the first quarter of 2015. Loss from continuing operations before benefit for income taxes was $15.7 million. For the year ending December 31, 2015, the company expects net revenue to be in the range of $2.5 billion to $2.6 billion; and non- GAAP adjusted net income from continuing operations available to common stockholders in the range of $2.40 to $2.50 per diluted share.

Alere Inc. to Report Q1, 2015 Results on May 05, 2015

Alere Inc. announced that they will report Q1, 2015 results at 9:00 AM, Eastern Standard Time on May 05, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALR:US $51.30 USD +0.49

ALR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Bio-Rad Laboratories Inc $145.13 USD -0.67
BioMerieux €103.75 EUR +4.08
MEDNAX Inc $71.37 USD +0.28
PerkinElmer Inc $53.39 USD 0.00
STERIS Corp $69.13 USD -0.51
View Industry Companies
 

Industry Analysis

ALR

Industry Average

Valuation ALR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.8x
Price/Book 3.2x
Price/Cash Flow 358.0x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALERE INC, please visit www.alere.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.